The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical-genomic sub-classification of high-risk prostate cancer: Implications for tailoring therapy and clinical trial design.
 
Vinayak Muralidhar
No Relationships to Disclose
 
Mohammed Alshalalfa
Employment - Deciphera
 
Daniel Eidelberg Spratt
Consulting or Advisory Role - Blue Earth Diagnostics; Janssen Oncology
 
Yang Liu
Employment - GenomeDx
 
R. Jeffrey Karnes
No Relationships to Disclose
 
Edward M. Schaeffer
Consulting or Advisory Role - Abbvie; OPKO Diagnostics
 
Elai Davicioni
Employment - Decipher Biosciences; GenomeDx
Leadership - Decipher Biosciences; GenomeDx
Stock and Other Ownership Interests - Decipher Biosciences; GenomeDx
Patents, Royalties, Other Intellectual Property - CANCER DIAGNOSTICS USING BIOMARKERS 20140066323
Travel, Accommodations, Expenses - GenomeDx
 
Felix Y Feng
Leadership - PFS Genomics
Stock and Other Ownership Interests - Nutcracker Therapeutics, Inc.; PFS Genomics; SerImmune
Honoraria - Genentech
Consulting or Advisory Role - Bayer; Blue Earth Diagnostics; Celgene; EMD Serono; Genzyme; Janssen Biotech; Medivation/Astellas
Research Funding - Zenith Epigenetics
Patents, Royalties, Other Intellectual Property - I helped develop a molecular signature to predict radiation resistance in breast cancer, and this signature was patented by the University of Michigan, my employer. It is in the process of being licensed to PFS Genomics, a company that I helped found. (Inst)
 
Eric A. Klein
Consulting or Advisory Role - Cellanyx Diagnostics; GRAIL
 
Jeffrey J. Tosoian
No Relationships to Disclose
 
Alejandro Berlin
No Relationships to Disclose
 
Robert Benjamin Den
No Relationships to Disclose
 
Paul L. Nguyen
Stock and Other Ownership Interests - Augmenix; Volatilyx (I)
Consulting or Advisory Role - Astellas Pharma; Augmenix; Augmenix; Bayer; Biogen (I); Blue Earth Diagnostics; Boston Scientific; Coda; Dendreon; Ferring; GenomeDx; GigaGen (I); Janssen Oncology; Medivation; Nanobiotix
Research Funding - Astellas Pharma; Janssen; Nanobiotix; Wako Diagnostics (I)
Patents, Royalties, Other Intellectual Property - Wife has a patent on volatile diagnostics of infections (I)
Travel, Accommodations, Expenses - Ferring